Cancer Therapy News and Research

RSS

Important milestone for any cancer therapy that will be useful for treating patients

Mayo Clinic researchers have manipulated a human antibody to induce an anti-tumor response in living mice that consistently curbs - and often cures - malignant melanoma, one of the most lethal forms of skin cancer and the most common cancer of young adults.

15 Jul 2004

New early breast cancer treatment significantly reduces the risk of cancer returning

Marking the first major treatment advance since tamoxifen's introduction over 25 years ago, Canada's leading oncologists and breast cancer patient support and advocacy groups gathered to applaud a new era in treatment for early breast cancer.

15 Jul 2004

Educating patients can help limit side effects of chemotherapy and radiation

A new study finds patients about to undergo chemotherapy or radiation expect a high number of side effects, and that age, gender, educational background, and the type of cancer all influence how many side effects a patient expects.

12 Jul 2004

Chromatin array a new technology for examining DNA

A new technique for examining DNA is giving scientists a more detailed picture of which genes have the propensity for activation, offering a new tool for understanding how genes function and possibly for diagnosing disease.

8 Jul 2004

Chemoradioimmunotherapy for advanced breast cancer

A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo- and radioresistant mechanisms was by presented by Dr John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital

8 Jul 2004

Combining targeted immunotherapy with chemotherapy and radiation therapy to successfully kill metastatic tumour cells

A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo and radioresistant mechanisms was by presented by Dr. John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital

7 Jul 2004

M. D. Anderson Cancer Center is ranked the nation’s top cancer hospital in U.S.

For the third consecutive year and fourth time in five years, The University of Texas M. D. Anderson Cancer Center is ranked the nation’s top cancer hospital in U.S. News & World Report’s “America’s Best Hospitals” survey, published in the magazine’s July 12 issue.

4 Jul 2004

TUNA therapy results in significantly reduced erectile dysfunction

Comparing five-year results of Medtronic TUNA® Therapy (transurethral needle ablation) to surgery for 121 men in their mid-60s with lower urinary tract symptoms caused by an enlarged prostate, a team of urologists found that “for appropriately selected patients with bothersome voiding symptoms, TUNA is an attractive treatment option.”

1 Jul 2004

Successes in frozen ovarian tissue technology may offer hope to women being treated for cancer

Doctors in Denmark have succeeded in producing a two-cell embryo after ovarian tissue was removed, frozen, and then thawed and replaced two years later.

29 Jun 2004

Chemotherapy agents as well as the newest biologic and targeted cancer therapy drugs, can harm a patient’s heart

Cancer treatments, including the most commonly used chemotherapy agents as well as the newest biologic and targeted therapy drugs, can harm a patient’s heart, sometimes fatally

29 Jun 2004

Iraqi doctors and senior nurses learn new techniques in head and neck cancer management

Thirty-two Iraqi Surgeons, Medical Oncologists and Senior Nurses travelled to the King Hussein Cancer Center in Amman, Jordan at the beginning of June to participate in a Seminar on Cancer Management.

29 Jun 2004

Continued commercial development of research into DNA repair

Recent developments have greatly improved the understanding of the mechanisms used by cells to identify and repair breaks in DNA, and the potential for drugs that target DNA repair in the treatment of a range of human diseases including cancer.

28 Jun 2004

Discovery of a gene-expression signature common to distinct types of cancer

Researchers at the University of Michigan, Johns Hopkins and the Institute of Bioinformatics in India have discovered a gene-expression "signature" common to distinct types of cancer

23 Jun 2004

More than half of head and neck cancer patients disabled by cancer or by cancer treatment

According to information in the article, more than 40,000 new cases of head and neck cancer are diagnosed annually in the United States, with 12,000 deaths each year. Patients with head and neck cancer often experience problems with eating and communicating, have pain, and have poor emotional well being and general functional status.

21 Jun 2004

Ageing population will have serious implications for the provision of cancer services

Cancer Research UK is highlighting the issue at its inaugural Wales Against Cancer conference in Cardiff today, which aims to focus policy makers on improving cancer treatment and promoting lifestyle changes for cancer prevention.

17 Jun 2004

For nearly 50% of women, hair loss was the most distressing side effect of chemotherapy

Information and support charity CancerBACUP has dramatically revised its booklet on hair loss - the most traumatic side effect of cancer treatment for many women. The revamped booklet also now includes practical advice for patients from minority ethnic groups.

14 Jun 2004

New treatment significantly improves long-term outlook for breast cancer survivors

An updated analysis from an international clinical trial of the drug letrozole was presented on June 8, 2004 at the American Society of Clinical Oncology annual meeting in New Orleans.

11 Jun 2004

New shaped-beam radiation delivery system provides patients with targeted cancer treatment

The Cleveland Clinic has installed the latest in radiation oncology technology, making it possible to treat a wider range of cancer patients with more precisely targeted radiation treatments that largely spare healthy tissues.

10 Jun 2004

Only half of gemcitabine dose may be activated in cancer patients

The study, presented in a poster discussion session by Jason Fisher, a student at the University of Pittsburgh School of Engineering, analyzed data from 31 cancer patients given 30-minute infusions of gemcitabine to determine what percentage of the drug dose was associated with concentrations that exceeded the body's ability to activate the drug.

9 Jun 2004

Atrasentan reduces cancer risk by 20 percent in men with advanced hormone-resistant prostate cancer

Recent clinical studies led by Johns Hopkins Kimmel Cancer Center researchers have found that a drug called atrasentan reduces the risk by 20 percent that cancer will progress in men with advanced hormone-resistant prostate cancer.

7 Jun 2004

Cancer Therapy News and Research

Important milestone for any cancer therapy that will be useful for treating patients

New early breast cancer treatment significantly reduces the risk of cancer returning

Educating patients can help limit side effects of chemotherapy and radiation

Chromatin array a new technology for examining DNA

Chemoradioimmunotherapy for advanced breast cancer

Combining targeted immunotherapy with chemotherapy and radiation therapy to successfully kill metastatic tumour cells

M. D. Anderson Cancer Center is ranked the nation’s top cancer hospital in U.S.

TUNA therapy results in significantly reduced erectile dysfunction

Successes in frozen ovarian tissue technology may offer hope to women being treated for cancer

Chemotherapy agents as well as the newest biologic and targeted cancer therapy drugs, can harm a patient’s heart

Iraqi doctors and senior nurses learn new techniques in head and neck cancer management

Continued commercial development of research into DNA repair

Discovery of a gene-expression signature common to distinct types of cancer

More than half of head and neck cancer patients disabled by cancer or by cancer treatment

Ageing population will have serious implications for the provision of cancer services

For nearly 50% of women, hair loss was the most distressing side effect of chemotherapy

New treatment significantly improves long-term outlook for breast cancer survivors

New shaped-beam radiation delivery system provides patients with targeted cancer treatment

Only half of gemcitabine dose may be activated in cancer patients

Atrasentan reduces cancer risk by 20 percent in men with advanced hormone-resistant prostate cancer

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News